Member 2018-2020

Member 2018-2020

Member 2021-2024

Member 2019-2022

Chair 2019-2022

Fabio Barili graduated at the University of Milan in 2000 as a medical doctor and in 2005 as a cardiac surgeon. In 2005 he completed a postdoctoral fellowship in minimally invasive surgery at the Columbia University and he obtained a Ph.D. degree in Surgery and Transplantation in 2008. Fabio completed his training focusing on percutaneous intervention for mitral valve disease. He also developed a keen interest in statistical methods and in 2009 he obtained a Master Degree in Health Statistics and Biometry in 2009. Currently, he is a surgeon of the Department of CardioVascular Surgery at S.Croce e Carle Hospital in Cuneo, Italy and the vice-president of the scientific committee of the Italian Society of Cardiac Surgery. His areas of interest are structural valve disease, minimally invasive surgery, statistical methods applied to cardiovascular field and the critical appraisal of scientific evidences.

Member 2019-2022

Stuart is an academic clinical lecturer in cardiothoracic surgery based in Manchester, UK. He has undertaken his specialist surgical training across the Northwest of England. His PhD focussed on risk prediction models in cardiovascular surgery. He has been a member of the UK National Adult Cardiac Surgical Audit research and audit committee and is a current member of the EACTS Research Methodology Task Force.

Member 2020-2021

Dr. Sabrina Siregar graduated as a medical doctor in 2009 at the University Medical Center Utrecht (UMCU). After her graduation she performed clinical work at the department of Cardio-Thoracic Surgery at the UMCU. In 2010 she started her research project on the outcomes of cardiac surgery in The Netherlands. This research project resulted in the thesis entitled "Safety in cardiac surgery", which led to a cum laude dissertation in 2013 at the University of Utrecht. During this period she also obtained a Master of Science in Clinical Epidemiology at the University of Utrecht. In 2014 she started her residency in Cardio-Thoracic Surgery at the Leiden University Medical Center. After her graduation as a cardio-thoracic surgeon in 2019, she continued her clinical work in Leiden. Her areas of interest are coronary artery bypass surgery and lung surgery. In addition, she continues to participate in national research projects regarding cardiac surgery risk scores and outcomes.

Member 2020-2021

Dr Emilia Bagiella is a Professor of Biostatistics in the Department of Population Science and Policy and the director of the Center for Biostatistics at the Icahn School of Medicine at Mount Sinai. She is the co-director of the MS in Biostatistics and of the PhD in Clinical Research at the Graduate School of Biomedical Science at Mount Sinai. Dr Bagiella’s interest has focused on enhancing translational research through innovative approaches to the design of clinical trials, training a new generation of translational researchers and continuing to garner federal support for evaluating the important clinical innovations that are emergent from clinical and translational investigators. The primary focus Dr Bagiella’s agenda is the design, conduct and analysis of clinical trials and epidemiological studies for novel therapeutics. She has been the PI of the Data Coordinating Center (DCC) for 7 federally funded multi-center clinical trials. She has developed new methods for the analysis of heart rate and blood pressure variability, the analysis of multiple outcomes, as well as for the analysis of case-control data. Dr Bagiella has dedicated a large part of her career to educational activities, through teaching in the Master’s and Doctoral Programs in Biostatistics, Public Health and Clinical Research, as well as leading several institutional educational initiatives.

Member 2020-2021

Hakim-Moulay Dehbi obtained his PhD in biostatistics from Imperial College London in 2017. Currently Hakim is Head of Statistics of the Comprehensive Clinical Trials Unit at UCL. His methodological research interests include the design of early-phase trials, including dose-finding trials as well as early-phase randomised designs. Dr Dehbi has more than 30 publications in prestigious medical journals, including the NEJM, the Lancet, and Statistics in Medicine. From an applied perspective, Hakim has mostly worked as statistician on cardiovascular and oncology trials.